Cancer Genomics Hub adds childhood cancer data

January 9, 2014 by Tim Stephens 

Researchers studying the genetics of childhood cancers now have access to a large and growing set of genomic data through the Cancer Genomics Hub (CGHub) operated by the University of California, Santa Cruz. The data come from a National Cancer Institute (NCI) initiative called TARGET (Therapeutically Applicable Research to Generate Effective Treatments), which aims to determine the molecular changes that drive the development and progression of five major types of childhood cancer.

A UCSC team led by bioinformatics expert David Haussler established CGHub in 2012 to manage primary sequence data from all of NCI's genomics research programs. These programs, which aim to improve cancer treatment by identifying the genetic drivers of cancer, require massive amounts of data to be shared among researchers throughout the country. Tissue samples from thousands of cancer patients are sent to sequencing centers for analysis, yielding huge files that can amount to more than 400 gigabytes (GB) per patient. The sequencing centers upload the files to CGHub, where the data are validated, organized, stored, and made available for downloading by researchers.

Cancer researchers who use CGHub are enthusiastic about its performance, said Haussler, a distinguished professor of biomolecular engineering at UCSC's Baskin School of Engineering. "We really are providing larger, more extensive data sets more efficiently than ever before," he said. "I'm extremely proud of the team, and it's inspiring to all of us to help with this effort, especially now with the addition of children's cancer data."

In recent months, downloads from CGHub have exceeded 1,000 terabytes (1 million GB) per month. Gad Getz, who leads cancer genome analysis at the Broad Institute of Harvard and MIT, told Haussler he has been able to download data from CGHub at an impressive rate of 4 terabytes per hour.

Easy Access

CGHub technical director Mark Diekhans said it is important for researchers to have easy access to these large datasets. "Accessing the data should not be an impediment to research. Making it easy requires not only the right infrastructure and good software, but also good user support," he said.

CGHub is a secure repository built with a planned storage capacity of 5 petabytes (5,000 terabytes). It uses GeneTorrent software, developed by Annai Systems, to enable very fast transfers of terabyte-scale data. CGHub staff built a specialized "data browser" that enables researchers to easily find and download the sequence files they need.

The first data uploaded to CGHub came from The Cancer Genome Atlas (TCGA) program, which is characterizing over 25 major types and subtypes of adult cancer. Led by NCI and the National Human Genome Research Institute, TCGA so far has produced nearly 500 terabytes of that researchers can now access through CGHub. In the past year, TCGA has yielded a series of landmark publications giving scientists a new understanding of several major types of cancer, including breast cancer, ovarian cancer, colorectal cancer, and, more recently, endometrial cancer and acute myeloid leukemia. These studies have revealed common genetic changes shared by different cancers and suggest new ways to classify cancers into subtypes that might be targeted by different treatments.

The TARGET program promises to deliver similar insights into children's cancers. About 400 terabytes of TARGET data have been made available on CGHub.

According to Haussler, the genetic changes in children's cancers tend to be less complex than those in adult cancer, which may make it easier to understand how those changes lead to cancer. "We may be able to decode children's cancers sooner than adult cancers, but we still need an enormous amount of data to figure this out. Our goal with CGHub is to have all this data at the ready for researchers," he said.

Identifying mutations

An important part of CGHub's work involves ensuring the compatibility of data coming from different sequencing centers. Different centers have used different methods to identify mutations in the genome sequences, so CGHub scientists have designed benchmarks and validation exercises to improve the agreement between different methodologies.

"We've done a lot of work to improve the precision of the diagnosis of mutations in tumors," Haussler said. "This is an essential prelude to what many feel will become common practice in cancer medicine. Knowing where the mutations are and how they operate is a key to having precision medicine for cancer. If we can build these tools and demonstrate their usefulness, we hope that someday it will be a routine part of cancer care to have your tumor sequenced so your doctor knows exactly what the mutations are and what treatments will be most effective."

In addition to TCGA and TARGET, data from the Cancer Genome Characterization Initiative (CGCI), which focuses on various types of pediatric and adult cancers, will be available from CGHub beginning mid-2014. Access to all of these datasets is restricted to researchers approved by the National Institutes of Health.

There is, however, one dataset on CGHub that is available for public access. This is the Cancer Cell Line Encyclopedia (CCLE), which provides genomic data for about 1,000 cell lines that are widely used in laboratory research. The CCLE project is a collaboration between the Broad Institute and the Novartis Institutes for Biomedical Research, partially funded by the NCI via TCGA.

"These genomes come from cell lines that are no longer associated with a particular person, so there aren't privacy concerns about making them publicly accessible," said Linda Rosewood, CGHub program director. "This set is very important as a research tool, but it can also be a valuable teaching tool that students can use to learn about bioinformatics and cancer genomics."

Explore further: UC Santa Cruz builds national data center for cancer genome research

Related Stories

UC Santa Cruz builds national data center for cancer genome research

May 1, 2012
The emerging field of "personalized" or "precision" medicine holds great promise in the fight against cancer. If scientists can identify the genetic changes that drive each patient's cancer cells, they can use that information ...

Pan-cancer studies find common patterns shared by different tumor types

September 26, 2013
Cancer encompasses a complex group of diseases traditionally defined by where in the body it originates, as in lung cancer or colon cancer. This framework for studying and treating cancer has made sense for generations, but ...

Kidney cancer progression linked to shifts in tumor metabolism

June 24, 2013
Investigators in The Cancer Genome Atlas (TCGA) Research Network have uncovered a connection between how tumor cells use energy from metabolic processes and the aggressiveness of the most common form of kidney cancer, clear ...

Researchers develop software tool for cancer genomics

August 26, 2013
Researchers at the Medical College of Wisconsin (MCW) have developed a new bioinformatics software tool designed to more easily identify genetic mutations responsible for cancers. The tool, called DrGaP, is the subject of ...

Oncogenic signatures mapped in TCGA a guide for the development of personalized therapy

September 27, 2013
Clinical trial design for new cancer therapies has historically been focused on the tissue of origin of a tumor, but a paper from researchers at Memorial Sloan-Kettering Cancer Center published on September 26 in Nature Genetics ...

Personalizing cancer treatments for the youngest of patients

December 18, 2013
The aim of personalizing cancer treatments by targeting genomic mutations in the cancer has seen rapid advances in recent years. Many of these targeted cancer therapies, however, have been more frequently identified for adult ...

Recommended for you

Stem cell therapy attacks cancer by targeting unique tissue stiffness

July 26, 2017
A stem cell-based method created by University of California, Irvine scientists can selectively target and kill cancerous tissue while preventing some of the toxic side effects of chemotherapy by treating the disease in a ...

Understanding cell segregation mechanisms that help prevent cancer spread

July 26, 2017
Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.

Study uncovers potential 'silver bullet' for preventing and treating colon cancer

July 26, 2017
In preclinical experiments, researchers at VCU Massey Cancer Center have uncovered a new way in which colon cancer develops, as well as a potential "silver bullet" for preventing and treating it. The findings may extend to ...

Compound shows promise in treating melanoma

July 26, 2017
While past attempts to treat melanoma failed to meet expectations, an international team of researchers are hopeful that a compound they tested on both mice and on human cells in a petri dish takes a positive step toward ...

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.